Publications by authors named "Susannah Ellsworth"

Claim this Profile
L
Lessons Learned About Acute and Late Toxicity After Two Decades of Experience With Pancreatic SBRT.
Susannah G Ellsworth, Mohamed Abdelhakiem, Baher Elgohari, Mohammed Mohammed, Jeffrey Shogan

J Natl Compr Canc Netw· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cargo Cult Radiotherapy: The Illusion of Precision in Advanced Technologies.
Susannah G Ellsworth, Christopher Wilke

Cureus· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survey of Changes in Absolute Lymphocyte Counts and Peripheral Immune Repertoire Diversity after External Beam Radiotherapy.
Susannah G Ellsworth, Alison Ross, Kevin R Y Shiue, Pranav Murthy, Miranda L Byrne-Steel

Radiat Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Declarations of Independence: How Embedded Multicollinearity Errors Affect Dosimetric and Other Complex Analyses in Radiation Oncology.
Susannah G Ellsworth, Peter S N van Rossum, Radhe Mohan, Steven H Lin, Clemens Grassberger

Int J Radiat Oncol Biol Phys· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RE: Venkatesulu et al. (Letter to the Editor).
Susannah G Ellsworth, Radhe Mohan, Steven H Lin

Radiother Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX Plus Radiotherapy in Patients With Borderline Resectable Pancreatic Cancer-The A021501 Trial.
Aaron J Grossberg, Krishan R Jethwa, Susannah G Ellsworth

JAMA Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Adjuvant Chemotherapy Survival Outcomes Among Patients With Surgically Resected Pancreatic Carcinoma With Node-Negative Disease After Neoadjuvant Therapy.
Abdulrahman Y Hammad, Jacob C Hodges, Samer AlMasri, Alessandro Paniccia, Kenneth K Lee, Susannah G Ellsworth

JAMA Surg· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of stereotactic body radiotherapy in hepatocellular carcinoma: guidelines and evidences.
Yulin Hu, Caining Zhao, Ren Ji, Wenqi Chen, Qi Shen, Susannah Ellsworth

J Natl Cancer Cent· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC.
Wang Jing, Ting Xu, Lirong Wu, Pablo B Lopez, Clemens Grassberger, Susannah G Ellsworth

JTO Clin Res Rep· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study.
Quisette P Janssen, Jacob L van Dam, Laura R Prakash, Deesje Doppenberg, Christopher H Crane, Susannah G Ellsworth

J Natl Compr Canc Netw· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Size Differences Between Preoperative Endoscopic Ultrasound and Postoperative Pathology for Neoadjuvant-Treated Pancreatic Ductal Adenocarcinoma Predict Patient Outcome.
Rohit Das, Kevin McGrath, Natalie Seiser, Katelyn Smith, Shikhar Uttam, Susannah Ellsworth

Clin Gastroenterol Hepatol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of age with acute toxicities in NRG oncology combined modality lower GI cancer trials.
Noam VanderWalde, Jennifer Moughan, Stuart M Lichtman, Reshma Jagsi, Matthew Ballo, Susannah G Ellsworth

J Geriatr Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphocyte Depletion Rate as a Biomarker of Radiation Dose to Circulating Lymphocytes During Fractionated Partial-Body Radiation Therapy.
Susannah G Ellsworth, Anirudh Yalamanchali, Tim Lautenschlaeger, Stuart A Grossman, Clemens Grassberger

Adv Radiat Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617.
Jian-Yue Jin, Chen Hu, Ying Xiao, Hong Zhang, Rebecca Paulus, Susannah G Ellsworth

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting tumor position differences between deep inspiration and expiration in lung stereotactic body radiation therapy planning.
Christina Huang, Kevin Shiue, Greg Bartlett, Namita Agrawal, Mona Arbab, Susannah Ellsworth

Med Dosim· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Neoadjuvant Chemotherapy Versus Chemoradiation in Localized Pancreatic Cancer: A Case-Control Matched Analysis.
Asmita Chopra, Jacob C Hodges, Adam Olson, Steve Burton, Susannah G Ellsworth

Ann Surg Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pancreatic Cancer Multidisciplinary Clinic Eliminates Socioeconomic Disparities in Treatment and Improves Survival.
Richard S Hoehn, Caroline J Rieser, Sharon Winters, Lauren Stitt, Melissa E Hogg, Susannah G Ellsworth

Ann Surg Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation-Induced Lymphopenia Risks of Photon Versus Proton Therapy for Esophageal Cancer Patients.
Saba Ebrahimi, Gino Lim, Amy Liu, Steven H Lin, Susannah G Ellsworth

Int J Part Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.
Radhe Mohan, Amy Y Liu, Paul D Brown, Anita Mahajan, Jeffrey Dinh, Susannah Ellsworth

Neuro Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RE: Valstar et al., "The tubarial salivary glands: A potential new organ at risk for radiotherapy".
Susannah G Ellsworth, Karen M Winkfield, Joel S Greenberger

Radiother Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographic factors associated with missed follow-up among solid tumor patients treated at a large multi-site academic institution.
Samantha L Freije, Jordan A Holmes, Saleh Rachidi, Susannah G Ellsworth, Richard C Zellars

Future Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Specific Lymphocyte Loss Kinetics as Biomarker of Spleen Dose in Patients Undergoing Radiation Therapy for Upper Abdominal Malignancies.
Anirudh Yalamanchali, Hong Zhang, Ke Colin Huang, Radhe Mohan, Steven H Lin, Susannah G Ellsworth

Adv Radiat Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiosurgery dose reduction for brain metastases on immunotherapy (RADREMI): A prospective phase I study protocol.
Shearwood McClelland, Tim Lautenschlaeger, Yong Zang, Nasser H Hanna, Kevin Shiue, Susannah G Ellsworth

Rep Pract Oncol Radiother· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A framework for modeling radiation induced lymphopenia in radiotherapy.
Jian-Yue Jin, Todd Mereniuk, Anirudh Yalamanchali, Weili Wang, Mitchell Machtay, Susannah Ellsworth

Radiother Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Karnofsky performance status is independently predictive of death within 30 days of intracranial radiation therapy completion for metastatic disease.
Shearwood McClelland Iii, Namita Agrawal, May F Elbanna, Kevin Shiue, Gregory K Bartlett, Susannah G Ellsworth

Rep Pract Oncol Radiother· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis